-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Ensysce Biosciences, Inc. annual/quarterly Net Cash Provided by (Used in) Investing Activities history and growth rate from Q4 2017 to Q1 2022.
- Ensysce Biosciences, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2022 was $4.5K.
- Ensysce Biosciences, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $4.5K.
- Ensysce Biosciences, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2020 was $183M, a 1447% increase from 2019.
- Ensysce Biosciences, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2019 was $11.9M, a 1313% increase from 2018.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)